Matches in Wikidata for { <http://www.wikidata.org/entity/Q92953485> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92953485 description "article scientifique publié en 2019" @default.
- Q92953485 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92953485 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92953485 description "scientific article published on 19 June 2019" @default.
- Q92953485 description "wetenschappelijk artikel" @default.
- Q92953485 description "наукова стаття, опублікована 19 червня 2019" @default.
- Q92953485 name "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 name "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 type Item @default.
- Q92953485 label "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 label "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 prefLabel "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 prefLabel "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 P1433 Q92953485-04C0CDB1-F21D-472A-BBB5-E81D784552CB @default.
- Q92953485 P1476 Q92953485-128C3CB3-E425-40DB-9E60-CFF4541733E2 @default.
- Q92953485 P2093 Q92953485-12ED65A1-3D9A-4A25-AE20-66F9E43351CE @default.
- Q92953485 P2093 Q92953485-22BE94E2-B36A-450A-8F84-99EB394F2D25 @default.
- Q92953485 P2093 Q92953485-25EFF6EB-2705-47A4-A760-1BA0F1C310B3 @default.
- Q92953485 P2093 Q92953485-40C694AF-D91F-42A5-8D5C-75185C22E96A @default.
- Q92953485 P2093 Q92953485-803444BE-3E03-4A80-98A0-EE2CFC15976E @default.
- Q92953485 P2093 Q92953485-9E7E9B0C-C47D-4FFE-BB2C-9044A5DF04A8 @default.
- Q92953485 P2093 Q92953485-A81CB1A3-24D0-4824-876C-AAC7BC9D8E74 @default.
- Q92953485 P2093 Q92953485-D5153032-DC42-4B4C-B5EE-B15BBC48F975 @default.
- Q92953485 P304 Q92953485-AFECBD88-BCC4-4889-BB57-CF491E6CF864 @default.
- Q92953485 P31 Q92953485-AEBC4876-282F-4026-84E6-4E1A22532F42 @default.
- Q92953485 P356 Q92953485-6FA4258D-2A24-479C-B201-3A17C0AB50DC @default.
- Q92953485 P478 Q92953485-9C7F937F-AA75-4777-B0AD-B185475AE2A0 @default.
- Q92953485 P577 Q92953485-EF7BD763-67B6-4D68-B0FE-6548DD1A49FC @default.
- Q92953485 P698 Q92953485-DA6907BD-06C2-4890-A7B1-D874DD0919A9 @default.
- Q92953485 P921 Q92953485-4745C161-E653-47BC-9B2C-522B21388F82 @default.
- Q92953485 P921 Q92953485-7204C4B9-8B3B-467F-BC14-9E5B8E554B77 @default.
- Q92953485 P921 Q92953485-CC8DB5DF-0FC4-4FD4-B36E-08868EAAA29A @default.
- Q92953485 P356 J.EXER.2019.107697 @default.
- Q92953485 P698 31228461 @default.
- Q92953485 P1433 Q15754753 @default.
- Q92953485 P1476 "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization" @default.
- Q92953485 P2093 "Alfredo García-Layana" @default.
- Q92953485 P2093 "Carolina Boiero" @default.
- Q92953485 P2093 "Daniel Allemandi" @default.
- Q92953485 P2093 "Inés Luis de Redín" @default.
- Q92953485 P2093 "Juan M Irache" @default.
- Q92953485 P2093 "Juan M Llabot" @default.
- Q92953485 P2093 "Maite Agüeros" @default.
- Q92953485 P2093 "Sergio Recalde" @default.
- Q92953485 P304 "107697" @default.
- Q92953485 P31 Q13442814 @default.
- Q92953485 P356 "10.1016/J.EXER.2019.107697" @default.
- Q92953485 P478 "185" @default.
- Q92953485 P577 "2019-06-19T00:00:00Z" @default.
- Q92953485 P698 "31228461" @default.
- Q92953485 P921 Q1266519 @default.
- Q92953485 P921 Q413299 @default.
- Q92953485 P921 Q61231 @default.